Mary Fidler
Mary Fidler
Geverifieerd e-mailadres voor rush.edu
Geciteerd door
Geciteerd door
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
RS Herbst, P Baas, DW Kim, E Felip, JL Pérez-Gracia, JY Han, J Molina, ...
The Lancet 387 (10027), 1540-1550, 2016
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
EEW Cohen, D Soulières, C Le Tourneau, J Dinis, L Licitra, MJ Ahn, ...
The Lancet 393 (10167), 156-167, 2019
Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC)
SM Gadgeel, NA Pennell, MJ Fidler, B Halmos, P Bonomi, J Stevenson, ...
Journal of Thoracic Oncology 13 (9), 1393-1399, 2018
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
JH Newman, CB Chesson, NL Herzog, PK Bommareddy, SM Aspromonte, ...
Proceedings of the National Academy of Sciences 117 (2), 1119-1128, 2020
Esophageal carcinoma advances in treatment results for locally advanced disease
A Herskovic, W Russell, M Liptay, MJ Fidler, M Al-Sarraf
Annals of oncology 23 (5), 1095-1103, 2012
PTEN, RASSF1 and DAPK site‐specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients
L Buckingham, L Penfield Faber, A Kim, M Liptay, C Barger, S Basu, ...
International journal of cancer 126 (7), 1630-1639, 2010
Treatment of advanced squamous cell carcinoma of the lung: a review
BA Derman, KF Mileham, PD Bonomi, M Batus, MJ Fidler
Translational lung cancer research 4 (5), 524, 2015
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
RS Herbst, P Baas, JL Perez-Gracia, E Felip, DW Kim, JY Han, JR Molina, ...
Annals of Oncology 30 (2), 281-289, 2019
Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls
MJ Fidler, DD Shersher, JA Borgia, P Bonomi
Therapeutic advances in medical oncology 4 (2), 51-60, 2012
Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer
BA Derman, JN Macklis, MS Azeem, S Sayidine, S Basu, M Batus, ...
BMC cancer 17, 1-6, 2017
Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
DM Cognetti, JM Johnson, JM Curry, ST Kochuparambil, D McDonald, ...
Head & neck 43 (12), 3875-3887, 2021
Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non‐small cell lung cancer in the National Cancer Data Base
DJ Sher, M Koshy, MJ Liptay, MJ Fidler
Cancer 120 (13), 2060-2068, 2014
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non–small cell lung cancer patients treated with …
MJ Fidler, A Argiris, JD Patel, DH Johnson, A Sandler, VM Villaflor, ...
Clinical cancer research 14 (7), 2088-2094, 2008
Health-related quality of life in KEYNOTE-010: a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1 …
F Barlesi, EB Garon, DW Kim, E Felip, JY Han, JH Kim, MJ Ahn, MJ Fidler, ...
Journal of Thoracic Oncology 14 (5), 793-801, 2019
Cost-effectiveness analysis of chemoradiation therapy versus transoral robotic surgery for human papillomavirus–associated, clinical N2 oropharyngeal cancer
DJ Sher, MJ Fidler, RB Tishler, K Stenson, S Al-Khudari
International Journal of Radiation Oncology* Biology* Physics 94 (3), 512-522, 2016
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients …
MJ Edelman, MT Tan, MJ Fidler, RE Sanborn, G Otterson, LV Sequist, ...
Journal of Clinical Oncology 33 (2), 189, 2015
Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer
DJ Sher, MJ Fidler, MJ Liptay, M Koshy
Lung Cancer 88 (3), 267-274, 2015
The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients
MJ Fidler, CL Fhied, J Roder, S Basu, S Sayidine, I Fughhi, M Pool, ...
BMC cancer 18, 1-9, 2018
Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing
V Dandekar, T Morgan, J Turian, MJ Fidler, J Showel, T Nielsen, ...
Oral oncology 50 (5), 520-526, 2014
Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy
S Garg, BT Gielda, K Kiel, JV Turian, MJ Fidler, M Batus, P Bonomi, ...
Practical radiation oncology 4 (5), 342-348, 2014
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20